Management of Postoperative Pain With Preemptive Analgesia in Cesarean Section

• Status: Unknown status
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mark Kosanovich
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• adult pregnant women to age 45 with scheduled cesarean sections at Mercy Hospital and Medical Center

Exclusion Criteria:

• Emergent cesarean sections and subjects with contraindications to bupivacaine